# | Title | Journal | Year | Citations |
---|
1 | A new and rapid colorimetric determination of acetylcholinesterase activity | Biochemical Pharmacology | 1961 | 23,305 |
2 | Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Biochemical Pharmacology | 1973 | 12,583 |
3 | Digitoxin metabolism by rat liver microsomes | Biochemical Pharmacology | 1975 | 3,820 |
4 | Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Biochemical Pharmacology | 1995 | 2,561 |
5 | Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung | Biochemical Pharmacology | 1971 | 2,405 |
6 | Lysosomotropic agents | Biochemical Pharmacology | 1974 | 1,870 |
7 | A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin | Biochemical Pharmacology | 1999 | 1,870 |
8 | Curcumin as “Curecumin”: From kitchen to clinic | Biochemical Pharmacology | 2008 | 1,815 |
9 | Ginseng pharmacology | Biochemical Pharmacology | 1999 | 1,742 |
10 | Some observations upon a new inhibitor of monoamine oxidase in brain tissue | Biochemical Pharmacology | 1968 | 1,582 |
11 | Molecular targets of dietary agents for prevention and therapy of cancer | Biochemical Pharmacology | 2006 | 1,501 |
12 | Flavonoids, a class of natural products of high pharmacological potency | Biochemical Pharmacology | 1983 | 1,350 |
13 | Flavonoids are scavengers of superoxide anions | Biochemical Pharmacology | 1988 | 1,337 |
14 | NF-κB activation by reactive oxygen species: Fifteen years later | Biochemical Pharmacology | 2006 | 1,328 |
15 | Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450 | Biochemical Pharmacology | 1985 | 1,255 |
16 | Biosynthesis of nitric oxide from l-arginine | Biochemical Pharmacology | 1989 | 1,197 |
17 | Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications | Biochemical Pharmacology | 2011 | 1,196 |
18 | Inflammation and cancer: How hot is the link? | Biochemical Pharmacology | 2006 | 1,171 |
19 | Presynaptic regulation of catecholamine release | Biochemical Pharmacology | 1974 | 1,109 |
20 | The changing faces of glutathione, a cellular protagonist | Biochemical Pharmacology | 2003 | 1,100 |
21 | Signal transduction to hypoxia-inducible factor 1 | Biochemical Pharmacology | 2002 | 1,058 |
22 | Inflammatory cytokines in vascular dysfunction and vascular disease | Biochemical Pharmacology | 2009 | 1,032 |
23 | Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature | Biochemical Pharmacology | 2008 | 999 |
24 | A sensitive and specific assay for the estimation of monoamine oxidase | Biochemical Pharmacology | 1963 | 970 |
25 | Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers | Biochemical Pharmacology | 2014 | 920 |
26 | Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation | Biochemical Pharmacology | 1989 | 873 |
27 | Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis | Biochemical Pharmacology | 2000 | 867 |
28 | Regulation of inflammation and redox signaling by dietary polyphenols | Biochemical Pharmacology | 2006 | 860 |
29 | The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation | Biochemical Pharmacology | 2013 | 855 |
30 | Oxidative stress and nuclear factor-κB activation | Biochemical Pharmacology | 2000 | 850 |
31 | Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia | Biochemical Pharmacology | 1990 | 845 |
32 | Isoforms of nitric oxide synthase Characterization and purification from different cell types | Biochemical Pharmacology | 1991 | 813 |
33 | Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance | Biochemical Pharmacology | 1994 | 769 |
34 | Antioxidant activity of curcumin and related compounds | Biochemical Pharmacology | 1976 | 761 |
35 | A novel biologically active seleno-organic compound—1 | Biochemical Pharmacology | 1984 | 759 |
36 | Regulation of metallothionein gene expression by oxidative stress and metal ions | Biochemical Pharmacology | 2000 | 727 |
37 | Cellular glutathione and thiols metabolism | Biochemical Pharmacology | 2002 | 722 |
38 | Stability of peptide nucleic acids in human serum and cellular extracts | Biochemical Pharmacology | 1994 | 685 |
39 | Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective | Biochemical Pharmacology | 2020 | 672 |
40 | Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis | Biochemical Pharmacology | 2008 | 658 |
41 | The importance of phospholipase-A2 in prostaglandin biosynthesis | Biochemical Pharmacology | 1976 | 657 |
42 | Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist | Biochemical Pharmacology | 1993 | 653 |
43 | Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential | Biochemical Pharmacology | 2010 | 648 |
44 | Angiogenesis: regulators and clinical applications | Biochemical Pharmacology | 2001 | 643 |
45 | Dietary n−6 and n−3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention | Biochemical Pharmacology | 2009 | 624 |
46 | Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease | Biochemical Pharmacology | 2008 | 623 |
47 | Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock | Biochemical Pharmacology | 2003 | 620 |
48 | Effects of flavonoids on immune and inflammatory cell functions | Biochemical Pharmacology | 1992 | 617 |
49 | A unique central tryptophan hydroxylase isoform | Biochemical Pharmacology | 2003 | 614 |
50 | Endothelium-derived relaxing factor | Biochemical Pharmacology | 1988 | 603 |